Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q1 2022 financial results on May 10, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for discussions regarding the results and business activities. This company is a leader in patient-centered healthcare-at-home solutions, offering products like sleep therapy equipment, diabetes supplies, and oxygen services through a network covering approximately 3.8 million patients in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported exceptional results for 2021, with revenues soaring to $2.45 billion, more than double the $1.06 billion from 2020. The company serves around 3.8 million patients annually, despite facing challenges from CPAP shortages. The fourth quarter revenue reached a record $702.1 million, marking a 102% increase year-over-year. Net income for the quarter was $22.9 million, a significant recovery from a net loss of $80.5 million in Q4 2020. AdaptHealth updated its 2022 guidance, expecting revenues between $2.825 billion and $3.025 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on February 18 at 9:20 am ET. A live webcast and replay will be available on the Investors section of AdaptHealth's website. AdaptHealth is a leader in providing home healthcare solutions, serving approximately 3.6 million patients across 50 states with a range of medical products and services.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q4 and full year 2021 financial results on February 24, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for management to discuss results and recent business activities. The company is a leader in healthcare-at-home solutions, catering to approximately 3.5 million patients annually across 700 locations. Their services include home medical equipment, diabetes supplies, oxygen therapy, and more, primarily serving Medicare, Medicaid, and commercial insurance beneficiaries.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in a fireside chat at the BofA Securities Home Care Conference on Monday, December 6, at 3:40 pm ET. Key executives, including Steve Griggs (CEO), Josh Parnes (President), and Jason Clemens (CFO), will represent the company. AdaptHealth serves around 3.5 million patients annually and offers a wide range of medical products and services across all 50 states, partnering with various healthcare providers to improve patient care.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced that CFO Jason Clemens will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Thursday, December 2 at 9:00 am ET. The company provides a range of services including home medical equipment and supplies, focusing on patient-centered care. With a network of over 700 locations, AdaptHealth serves approximately 3.5 million patients across all 50 states, offering solutions for chronic conditions and various medical needs.
AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available on-demand starting Thursday, November 18, before market open, accessible via the Investors section of AdaptHealth’s website (www.adapthealth.com). AdaptHealth is a leader in providing healthcare-at-home solutions, reaching approximately 3.5 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17 at 1:20 pm ET. A live webcast will be available through the Investors section of AdaptHealth’s website. The company is a leader in providing patient-centered, healthcare-at-home solutions, serving approximately 3.5 million patients annually across 716 locations in 47 states with a full suite of medical products.
AdaptHealth Corp. (NASDAQ: AHCO) reported a record net revenue of $653.3 million for Q3 2021, a 130% increase from the previous year, alongside a net income of $58.1 million, reversing a $51 million loss. Adjusted EBITDA surged 194% to $156.3 million. The company completed six acquisitions and has increased its fiscal 2021 revenue guidance to $2.41-$2.46 billion. For 2022, guidance is set at $2.70-$2.90 billion in revenue. Management is confident in driving organic growth through strategic acquisitions despite market challenges.
AdaptHealth Corp. (NASDAQ: AHCO) is set to release its third quarter 2021 financial results before the market opens on
FAQ
What is the current stock price of AdaptHealth (AHCO)?
What is the market cap of AdaptHealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
